Drug Trial Radar · NCT02765009
Effects of Fluid Balance Control in Critically Ill Patients
Last checked: Nov 19, 2026Latest source record: Sep 22, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,411
Actual
Start
Jun 1, 2016
Primary completion
Jul 31, 2019
Study completion May 25, 2020
Sponsor
- Lead sponsor
- Central Hospital, Nancy, FranceAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Ministry of Health, France
- First posted
- May 6, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Most ICU patients develop a positive fluid balance, mainly during the two first weeks of their stay. The causes are multifactorial: a reduced urine output subsequent to shock state, positive pressure mechanical ventilation, acute renal failure, post-operative period of major surgical procedures, and simultaneous fluid loading to maintain volemia and acceptable arterial pressure. Additionally, the efficacy of fluid loading is frequently suboptimal, in relation to severe hypoalbuminemia and inflammatory capillary leakage. This results usually in a cumulated positive fluid balance of more than 10 litres at the end of the first week of stay. A high number of studies have showed that such a positive fluid balance was an independent factor of worse prognosis in selected populations of ICU patients: acute renal failure, acute respiratory distress syndrome (ARDS), sepsis, post-operative of high risk surgery. However, little is known about the putative causal role of positive fluid balance by itself on outcome. However, in two randomized controlled studies in patients with ARDS, a strategy of fluid balance control has been demonstrated to reduce time under mechanical ventilation and ICU length of stay with no noticeable adverse effects. Although avoiding fluid overload is now recommended in ARDS management, there is no evidence that this approach would be beneficial in a more general population of ICU patients (i.e. with sepsis, acute renal failure, mechanical ventilation). In addition, fluid restriction -mainly if applied early could be deleterious in reducing both tissue oxygen delivery and perfusion pressure. There is a place for a prospective study comparing a "conventional" attitude based on liberal fluid management throughout the ICU stay with a restrictive approach aiming at controlling fluid balance, at least as soon as the patient circulatory status is stabilized. The latter approach would use a simple algorithm using fluid restriction and diuretics based on daily weighing, a common procedure in the ICU, probably more reliable than cumulative measurement of fluid movements in patients whose limits have been underlined.
Conditions
- Fluid Shifts
- Critical Care
Interventions
diureticsDrug
Used to reduce fluid overload as evidenced by weight gain
albuminDrug
Used to reduce fluid overload in addition with diuretics in hypoalbuminemic patients
fluid restrictionOther
Used to reduce fluid overload
renal replacementDevice
Used to reduce fluid overload in patients with renal replacement
Primary outcomes
What the sponsor says the trial is designed to measure.
- All-cause mortality at 60 days after inclusionTime frame: 60 days
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Hopital Nord Franche-Comté
Belfort, France
Centre Hospitalier Universitaire
Dijon, France
Centre Hospitalier Universitaire
Lyon, France
Centre Hospitalier Régional
Metz, France
Centre Hospitalier Régional et Universitaire
Nancy, France
Groupe Hospitalier Saint Joseph
Paris, France
Centre Hospitalier intercommunal
Poissy, France
Centre Hospitalier Régional et Universitaire
Strasbourg, France
CentreHospitalier Régional et universitaire
Strasbourg, France
Centre Hospitalier Régional
Thionville, France
Centre Hospitalier
Verdun, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.